Syros Pharmaceuticals (SYRS)
$6.27
0.21 (3.47%)
SYRS Stock Earnings: Syros Pharmaceuticals Beats EPS for Q1 2024
SYRS stock results show that Syros Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.
Top 5 Stocks for 2024
![](https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif)
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
![](https://investorplace.com/wp-content/themes/InvestorPlaceV2/dist/images/analysts_thumb_louis_navellier_new_tiny.jpg)
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
![](https://investorplace.com/wp-content/themes/InvestorPlaceV2/dist/images/analysts_thumb_louis_navellier_new_tiny.jpg)
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
![](https://investorplace.com/wp-content/themes/InvestorPlaceV2/dist/images/analysts_thumb_louis_navellier_new_tiny.jpg)
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
![](https://investorplace.com/wp-content/themes/InvestorPlaceV2/dist/images/analysts_thumb_louis_navellier_new_tiny.jpg)
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
129.13M
PE Ratio
-7.38
EPS
-0.85
Volume (Avg. Vol.)
65,493
Day's Range
$5.89 - $6.32
52-Week Range
$2.09 - $8.17
Dividend & Yield
N/A (N/A)